Analytik Jena Sells Site in Eisfeld

New investor acquiring entire Optics business unit as well as component production for analytical technology

19-Apr-2016 - Germany

Analytik Jena AG is selling its Eisfeld site as of the end of April 30, 2016, to NOBLEX GmbH. NOBLEX GmbH is a subsidiary of the Frankfurt-based investment company VF Capital GmbH. A corresponding agreement was signed this past Friday by both companies. In addition to the business with optical consumer products under the brand name DOCTER, the transaction includes the production of parts, assemblies, and components for use in analytical technology, which Analytik Jena distributes as part of its core business.

Important points regarding the further strategic cooperation of both contractual partners were covered under the agreement. One key point is that NOBLEX will continue to produce parts, assemblies, and components for use in Analytik Jena products. In addition to the Optics business, which will be continued independently, this agreement means a very good level of production capacity utilization for the site’s new owner as well as assured supply quality for the product portfolio of Analytik Jena. The corresponding framework supply agreement has initially been agreed upon for three years.

“Analytik Jena will concentrate on its core business of lab analysis in the future as part of its strategic orientation,” said Klaus Berka, Chief Executive Officer of Analytik Jena AG. “Retaining the jobs of all employees at the Eisfeld site into the future was at the forefront of our negotiations regarding the sale of the site to the investor. We have also provided contractual assurance to the new owner that Analytik Jena will continue to be a primary buyer for the analytical technology components produced there, thus remaining the site’s most important customer.”

In the Optics business unit, Analytik Jena developed and produced binoculars, telescopic sights for hunting, and universally deployable reflex sights under the brand name DOCTER at the long-standing Eisfeld location in southern Thuringia. The business, which had been stagnating in recent years, was able to grow through new products in the past two years.NOBLEX GmbH will maintain and expand on the many years of expertise built up at the Eisfeld site.

“Our group of companies focuses especially on investments in manufacturing companies. With the Analytik Jena site in Eisfeld, we have acquired a very experienced production site with a history. Our goal is to continue to expand this site, make investments here, and continue the specialized training of the employees. We will offer all employees long-term prospects and build upon them so that we can continue to collaborate with Analytik Jena in a way that is successful for both parties and continues for a long time,” said Peter Vey, CEO of NOBLEX GmbH.

“Analytik Jena’s focus on its core competencies in the instrument business is an important prerequisite for the continued expansion of our business around the world and for targeted investments,” Berka continued. Since March 2016, Analytik Jena AG has been a wholly owned subsidiary of the family-owned Swiss company Endress+Hauser.

https://www.bionity.com/en/news/158846/analytik-jena-sells-site-in-eisfeld.html